Accuracy of telomerase in cervical lesions: A systematic review

International Journal of Gynecological Cancer

Volumn 17, Issue 6, 2007, Pages 1205-1214

  Rosa, M I ^a,b   Medeiros, L R ^a   Bozzetti, M C ^a   Fachel, J ^a   Wendland, E ^a   Zanini, R R ^a   Moraes, A B ^a   Rosa, D D ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Alfa Institute of Gastroenterology   (Brazil)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Accuracy; Cervical intraepithelial neoplasia; Diagnosis; Meta analysis; Systematic review; Telomerase

Indexed keywords

PARAFFIN; TELOMERASE;

CANCER RISK; CARCINOGENESIS; CONFIDENCE INTERVAL; DATA SYNTHESIS; DIAGNOSTIC ACCURACY; HUMAN; INFORMATION PROCESSING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UTERINE CERVIX CANCER;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; ODDS RATIO; SENSITIVITY AND SPECIFICITY; TELOMERASE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 35949003130     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00980.x     Document Type: Review

References (28)

1. Parkim DM. Global cancer statistics in year 2000. Lancet Oncol 2001 2: 533 43.
2. Park TK. Adjuvant therapy in cervical cancer patients with high risk factors. Yonsei Med J 1997 38: 255 60.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002 55: 244 65.
4. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda Sytem Terminology. Am Fam Physician 2003 68: 1992 8.
5. Greider CW. Telomerase activation. One step on the road to cancer? Trends Genet 1999 15: 109.
6. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994 266: 2011 5.
7. Ahmed A, Tollefsbol T. Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer. J Am Geriatr Soc 2003 51: 116 22.
8. Lijmer JG, Mol BW, Heisterkamp S et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999 282: 1061 6.
9. Jaeschke R, Guyatt G, Sackett DL for the evidence-based working group. User's guides to the medical literature. II. How to use an article about a diagnostic test. A. Are the results of study valid? JAMA 1994 271: 389 91.
10. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 2003 138: 40 5.
11. Cochrane Methods Working Group on Systematic Reviews of Screening and Diagnostic Tests. Recommended methods. Available at: http://www.cochrane.org/ cochrane/sadtdoc1.htm. Accessed January 25, 2004.
12. Phillips B, Ball C, Sackett D et al. Oxford centre for evidence-based medicine, level of evidence and grades of recommendations (May 2001). Available at http://www.cebm.net/background.asp. Accessed February 23, 2004.
13. Altman D. Some common problems in medical research. In: Altman D, ed. Practical statistics for medical research, 9th edn. London, England: Chapman, 1999: 403 9.
14. Altman D. Relation between two continuous variables. In: Altman D, ed. Practical statistics for medical research, 9th edn. London, England: Chapman, 1999: 277 99.
15. Deeks JJ. Systematic reviews of evaluation of diagnostic and screening tests. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in health care: meta-analysis in context, 2nd edn. London, England: BMJ Publishing 2001: 248 82.
16. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Randon effects methods for combining study estimates. In: Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F, eds. Methods for meta-analysis in medical research, 1st edn. Chichester, England: John Wiley 2000: 73 86.
17. Deekes JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context, 2nd edn. London, England: BMJ Publishing 2001: 248 82.
18. Iwasaka T, Zheng PS, Yokoyama M, Fukuda K, Nakao Y, Sugimori H. Telomerase activation in cervical neoplasia. Obstet Gynecol 1998 91: 260 2.
19. Mutirangura A, Sriuranpong V, Termrunggraunglert W et al. Telomerase activity and human papillomavirus in malignant, pre-malignant and benign cervical lesions. Br J Cancer 1998 78: 933 9.
20. Nagai N, Oshita T, Murakami J, Ohama K. Semiquantative analysis of telomerase activity in cervical cancer and precancerous lesion. Oncol Rep 1999 6: 325 8.
21. Nair P, Jayaprakash PG, Nair MK, Pillai MR. Telomerase, p53 and human papillomavirus infection in the uterine cervix. Acta Oncol 2000 39: 65 70.
22. Pao CC, Tseng CJ, Lin CY et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997 15: 1932 7.
23. Riethdorf S, Riethdorf L, Schulz G et al. Relationship between telomerase activation and HPV16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of uterine cervix. Int J Gynecol Pathol 2001 20: 177 85.
24. Shroyer KR, Thompson C, Enomoto T, Eskens JL, Shroyer L, McGregor JA. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of uterine cervix. Anat Pathol 1998 109: 153 62.
25. Snijders PJ, Duin MV, Walboomers JM et al. Telomerase activity exclusively in cervical carcinomas and subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 1998 58: 3812 8.
26. Wang SZ, Sun JH, Zhang W et al. Telomerase activity in cervical intraepithelial neoplasia. Chin Med J 2004 117: 202 6.
27. Wisman GB, Hollema H, de Jong S et al. Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear. J Clin Oncol 1998 16: 2238 45.
28. Irwig L, Tosteson ANA, Gatsonis C et al. Guidelines for meta-analysis evaluating diagnostic tests. Ann Intern Med 1994 120: 667 76.